Navigation Links
Sanofi-aventis Stands Behind the Safety of Lantus(R)
Date:6/26/2009

st marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

Contact: Lisa Buffington - sanofi-aventis, +1-908-981-6569, lisa.buffington@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
5. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
6. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
7. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
8. Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barretts Esophagus
9. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
10. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
11. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
(Date:3/27/2015)... 27, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... today announced that they have entered into ... and proprietary sd-rxRNA® technology for use in ... has the potential to result in novel, ... that could be a significant step toward ...
(Date:3/27/2015)... -- Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator ... imaging centers in China , ... under which Concord Medical Services (International) Pte Ltd, ... to acquire the Fortis Surgical Hospital from Fortis ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... 22 Endo Pharmaceuticals (Nasdaq: ENDP ) announced ... Drug Administration (FDA) that Endo,s new drug application (NDA) for ... to be crush resistant, has been granted priority review status. ... Drug User Fee Act (PDUFA) for Jan. 7, 2011. ...
... Kluwer Pharma Solutions , a leading provider of scientific ... announced today that the Adis journal PharmacoEconomics ... to comparative effectiveness research (CER).  CER seeks to compare ... as a means to improve patient healthcare and slow ...
Cached Medicine Technology:Special Issue of PharmacoEconomics to Focus on Comparative Effectiveness Research 2Special Issue of PharmacoEconomics to Focus on Comparative Effectiveness Research 3Special Issue of PharmacoEconomics to Focus on Comparative Effectiveness Research 4
(Date:3/27/2015)... Approximately 300 advocates participated in ... Lobby Day to lobby for physical education, active ... Everlast Climbing was especially interested in voicing ... would strengthen physical education programs by adopting new ... measures to strengthen physical education in schools. , ...
(Date:3/27/2015)... Since September 2014, the country singer has been ... having been in retirement for a period of 13 years. ... return to touring, and concert events have been booking quickly ... sell out for the two shows recently scheduled for May ... the inventory of discounted Garth Brooks tickets for sale. , ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Canadian ... the safe prescribing and utilization of medical cannabis ... Canada.MarijuanaDoctors.com’s network of doctors and clinics dedicated to ... MarijuanaDoctors.com, a trusted gateway for patients searching for ... and territories, recently launched their sub domain for ...
(Date:3/27/2015)... RI (PRWEB) March 27, 2015 April 2015 ... war – the Sesquicentennial. To honor America’s bloodiest war and ... Fort Adams Trust presents A Tribute to the Civil War ... PM, Friday, April 17, 2015, at the Jane Pickens Theater ... noted Civil War-Lincoln scholar, will serve as the master of ...
(Date:3/27/2015)... 2015 Yisrayl Hawkins, Pastor and Overseer at ... way to live in Peace is through the Laws of ... published this week. , The article titled, “Yahweh’s Way-The Great ... and how straying away from the original biblical instructions has ... system that has been created in the world is based ...
Breaking Medicine News(10 mins):Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2
... creating news is the new vaccine for preventing cervical cancer. ... issue of access to vaccines for sexually transmitted diseases this ... vaccine is to target the HPV that is human papillomavirus, ... also the major cause for cervical cancer. ,There ...
... malignant diseases which are responsible for number of deaths. Number ... subject. A new study suggests that true biological differences are ... confounded by Dr. Tim Byers, of the University of Colorado ... not due to the disparity in the access in health ...
... sneezed at//. ,The research carried out by Dr. ... 000 extra deaths were traced to the common flu in the ... just one more solid reason why people should get annual ... they also said people with heart disease should never forgo their ...
... called for a calm and rational approach to addressing illness outbreaks ... Broughton Hall in Melbourne. ,Dr Haikerwal said the ... it is not a time to be calling for dramatic changes ... carefully identify the causes for the outbreak and take all reasonable ...
... the pain and agony begin to subside over Monday’s ghastly student ... ‘loner’ killer Cho Seung-Hui began to take form. , ... be any stronger than this point of time. At the same ... ,The fact that Cho was a ‘disturbed’ student was ...
... President Dr Mukesh Haikerwal today called on the Federal ... to children, after a new study revealed// that two-thirds ... food. ,'This startling study demonstrates that ... children and young people,' Dr Haikerwal said. ...
Cached Medicine News:Health News:Will the Cervical Cancer Vaccine Have Long Term Benefits? 2Health News:The Flu- More Than Just That 2Health News:AMA Calls For Calm Approach To Aged Care Illness Outbreaks 2Health News:Virginia Tech. Shooter -Human Rights or Innocent Lives 2
... The HypercleanTM 22 fume containment ... as a one- or two-person ... fume containment system comes ... and four charcoal filters. (For ...
... steel, detachable disposable concentric needle has a ... (.08-in) brass plug connector. Needles sold in ... shielded cable with 5-pin DIN connector is ... nonsterile and may be autoclaved or disinfected ...
... The Strep B OIA test provides ... antigen directly from cervical or vaginal ... culture results are unknown at the ... B OIA offers physicians additional information ...
... is a high performance assay for the ... B with a simple, easy-to-use test that ... minutes. Assay advantages include superior performance with ... to 14-day viral culture enables you to ...
Medicine Products: